Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:58:45.566Z.
Calculation as of: 2026-10-06T21:58:45.566Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f0d9278b3abed9c67286a4c42ed3cbe71797fc66aa4bad88dc285e5ed2b1466
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-05-04.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$63.78M
EV/FCF Ratio
N/A
TTM Avg
41.03x
3Y Avg
41.03x
5Y Avg
41.03x
Market Cap
$68.90M
EV/FCF Ratio
1.03x
TTM Avg
6.09x
3Y Avg
5.75x
5Y Avg
4.59x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XBiotech Inc. (XBIT) | $65.85M | N/A | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | 54.90x | 54.90x | 54.90x |
| iBio, Inc. (IBIO)vs › | $67.52M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 41.03x | 41.03x | 41.03x |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | N/A | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $63.02M | 14.40x | 12.61x | 12.61x | 118.68x |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 1.03x | 6.09x | 5.75x | 4.59x |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | N/A | 1.41x | 1.41x | 1.41x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2022-05-04 | 0.06x |
| 2022-05-03 | 0.10x |
| 2022-04-28 | 0.29x |
| 2022-04-20 | 0.13x |
| 2022-04-19 | 0.17x |
| 2022-04-18 | 0.18x |
| 2022-04-14 | 0.24x |
| 2022-04-13 | 0.40x |
| 2022-04-12 | 0.31x |
| 2022-04-11 | 0.36x |
| 2022-04-08 | 0.42x |
| 2022-04-07 | 0.50x |
| 2022-04-06 | 0.51x |
| 2022-04-05 | 0.54x |
| 2022-04-04 | 0.64x |
| 2022-04-01 | 0.59x |
| 2022-03-31 | 0.38x |
| 2022-03-30 | 0.43x |
| 2022-03-29 | 0.55x |
| 2022-03-28 | 0.62x |
| 2022-03-25 | 0.49x |
| 2022-03-24 | 0.63x |
| 2022-03-23 | 0.69x |
| 2022-03-22 | 0.80x |
| 2022-03-21 | 0.72x |
| 2022-03-18 | 0.81x |
| 2022-03-17 | 0.83x |
| 2022-03-16 | 0.62x |
| 2022-03-15 | 0.53x |
| 2022-03-14 | 0.51x |
| 2022-03-11 | 0.51x |
| 2022-03-10 | 0.62x |
| 2022-03-09 | 0.67x |
| 2022-03-08 | 0.59x |
| 2022-03-07 | 0.63x |
| 2022-03-04 | 0.71x |
| 2022-03-03 | 0.74x |
| 2022-03-02 | 0.86x |
| 2022-03-01 | 0.72x |
| 2022-02-28 | 0.92x |
| 2022-02-25 | 0.92x |
| 2022-02-24 | 0.89x |
| 2022-02-23 | 0.73x |
| 2022-02-22 | 1.04x |
| 2022-02-18 | 0.86x |
| 2022-02-17 | 0.80x |
| 2022-02-16 | 1.02x |
| 2022-02-15 | 1.09x |
| 2022-02-14 | 0.98x |
| 2022-02-11 | 1.04x |
| 2022-02-10 | 1.04x |
| 2022-02-09 | 1.17x |
| 2022-02-08 | 1.13x |
| 2022-02-07 | 1.05x |
| 2022-02-04 | 0.86x |
| 2022-02-03 | 0.87x |
| 2022-02-02 | 1.06x |
| 2022-02-01 | 1.28x |
| 2022-01-31 | 1.34x |
| 2022-01-28 | 1.20x |
| 2022-01-27 | 1.12x |
| 2022-01-26 | 1.21x |
| 2022-01-25 | 1.32x |
| 2022-01-24 | 1.17x |
| 2022-01-21 | 1.10x |
| 2022-01-20 | 1.18x |
| 2022-01-19 | 1.31x |
| 2022-01-18 | 1.47x |
| 2022-01-14 | 1.73x |
| 2022-01-13 | 1.62x |
| 2022-01-12 | 1.62x |
| 2022-01-11 | 1.78x |
| 2022-01-10 | 1.70x |
| 2022-01-07 | 1.60x |
| 2022-01-06 | 1.60x |
| 2022-01-05 | 1.56x |
| 2022-01-04 | 1.56x |
| 2022-01-03 | 1.69x |
| 2021-12-31 | 1.51x |
| 2021-12-30 | 1.54x |
| 2021-12-29 | 1.50x |
| 2021-12-28 | 1.42x |
| 2021-12-27 | 1.50x |
| 2021-12-23 | 1.58x |
| 2021-12-22 | 1.67x |
| 2021-12-21 | 1.58x |
| 2021-12-20 | 1.71x |
| 2021-12-17 | 1.70x |
| 2021-12-16 | 1.78x |
| 2021-12-15 | 1.61x |
| 2021-12-14 | 1.71x |
| 2021-12-13 | 1.51x |
| 2021-12-10 | 1.76x |
| 2021-12-09 | 1.86x |
| 2021-12-08 | 2.13x |
| 2021-12-07 | 1.92x |
| 2021-12-06 | 1.69x |
| 2021-12-03 | 1.47x |
| 2021-12-02 | 1.80x |
| 2021-12-01 | 1.82x |
| 2021-11-30 | 2.20x |
| 2021-11-29 | 2.09x |
| 2021-11-26 | 2.28x |
| 2021-11-24 | 2.31x |
| 2021-11-23 | 2.34x |
| 2021-11-22 | 2.33x |
| 2021-11-19 | 2.22x |
| 2021-11-18 | 2.35x |
| 2021-11-17 | 2.57x |
| 2021-11-16 | 2.85x |
| 2021-11-15 | 2.64x |
| 2021-11-12 | 3.17x |
| 2021-11-11 | 3.41x |
| 2021-11-10 | 3.41x |
| 2021-11-09 | 1.98x |
| 2021-11-08 | 2.11x |
| 2021-11-05 | 2.12x |
| 2021-11-04 | 2.18x |
| 2021-11-03 | 2.13x |
| 2021-11-02 | 1.89x |
| 2021-11-01 | 1.89x |
| 2021-10-29 | 1.63x |
| 2021-10-28 | 1.50x |
| 2021-10-27 | 1.43x |
| 2021-10-26 | 1.58x |
| 2021-10-25 | 1.50x |
| 2021-10-22 | 1.40x |
| 2021-10-21 | 1.36x |
| 2021-10-20 | 1.29x |
| 2021-10-19 | 1.13x |
| 2021-10-18 | 0.97x |
| 2021-10-15 | 1.06x |
| 2021-10-14 | 1.03x |
| 2021-10-13 | 0.94x |
| 2021-10-12 | 0.89x |
| 2021-10-11 | 1.04x |
| 2021-10-08 | 0.96x |
| 2021-10-07 | 0.78x |
| 2021-10-06 | 0.78x |
| 2021-10-05 | 0.74x |
| 2021-10-04 | 0.97x |
| 2021-10-01 | 1.07x |
| 2021-09-30 | 0.96x |
| 2021-09-29 | 1.04x |
| 2021-09-28 | 1.35x |
| 2021-09-27 | 1.72x |
| 2021-09-24 | 1.49x |
| 2021-09-23 | 1.60x |
| 2021-09-22 | 1.74x |
| 2021-09-21 | 1.91x |
| 2021-09-20 | 1.80x |
| 2021-09-17 | 2.18x |
| 2021-09-16 | 2.02x |
| 2021-09-15 | 2.06x |
| 2021-09-14 | 1.92x |
| 2021-09-13 | 1.98x |
| 2021-09-10 | 2.04x |
| 2021-09-09 | 2.01x |
| 2021-09-08 | 2.03x |
| 2021-09-07 | 2.04x |
| 2021-09-03 | 2.12x |
| 2021-09-02 | 2.19x |
| 2021-09-01 | 2.21x |
| 2021-08-31 | 2.14x |
| 2021-08-30 | 2.24x |
| 2021-08-27 | 2.20x |
| 2021-08-26 | 2.13x |
| 2021-08-25 | 2.08x |
| 2021-08-24 | 2.11x |
| 2021-08-23 | 2.12x |
| 2021-08-20 | 1.98x |
| 2021-08-19 | 1.87x |
| 2021-08-18 | 2.02x |
| 2021-08-17 | 2.18x |
| 2021-08-16 | 2.16x |
| 2021-08-13 | 2.14x |
| 2021-08-12 | 2.18x |
| 2021-08-11 | 2.22x |
| 2021-08-10 | 2.31x |
